BioWorld - Tuesday, June 16, 2026

BioWorld Science

Nov. 4, 2021

View Archived Issues

Bicycle Therapeutics targets nectin-4 and CD137 with BT-7480

Read More

WDR5 degrader MS-67 shows promise against AML in murine model

Read More

Colchicine shows promise in a rimmed vacuolar myopathy model

Read More

ADA2-mediated signaling promotes liver fibrosis in NAFLD

Read More

New and known compounds targeting PTPRD may treat AD, addiction and restless legs syndrome

Read More

Novel theranostic agent shows potential for immune-PET imaging and TRT in models of gliomas

Read More

Keaise Medicine patents TRXR inhibitors

Read More

Disarm Therapeutics discloses SARM1 inhibitors

Read More

Chinese researchers present new glucose-lowering agents

Read More

Jiangsu Chia Tai Tianqing Pharmaceutical describes HBV antivirals

Read More

Discovery of novel IDO1 inhibitors for the treatment of cancer

Read More

RAPT Therapeutics patents USP7 inhibitors

Read More

Versameb's VMB-100 shows promise for stress urinary incontinence in animal model

Read More

Defence Therapeutics' AccuVAC-PT001 COVID-19 vaccine completes toxicology studies in rabbits

Read More

SLC6A14 polymorphism tied to cystic fibrosis severity

Read More

Burning Rock to support testing of Impact's ATR inhibitor IMP-9064

Read More

Computational prodding of evolutionary history gives clues to gene variants

Read More